Literature DB >> 20864497

Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service.

Jennifer Ho1, Sophia Archuleta, Zuraidah Sulaiman, Dale Fisher.   

Abstract

BACKGROUND: The enrollment of intravenous drug users (IVDUs) into an outpatient parenteral antibiotic treatment (OPAT) service using a peripherally inserted central catheter (PICC) is controversial and often avoided. The National University Hospital in Singapore has a policy of permitting OPAT-based treatment of IVDU patients with appropriate medical indications. We report on our experiences.
METHODS: A prospective observational study was conducted on IVDU patients requiring parenteral antibiotics via an OPAT service from January 2005 to December 2009. Clinically appropriate patients were screened using pre-defined criteria and enrolled into our service, where standardized measures were enforced to prevent and detect PICC abuse and optimize treatment. Outcomes measured included mortality, completion of therapy, PICC abuse, and readmission for infective or treatment-related complications during OPAT and a 30 day follow-up period.
RESULTS: Twenty-nine IVDU patients received treatment in our OPAT service (total 675 patient-days). The median duration of therapy was 18 days (range 1-85). Infective endocarditis was the primary diagnosis in 42% of cases. Two patients (7%) had recrudescent infection after absconding during their inpatient stay. These two patients subsequently completed treatment in OPAT. There were no deaths or cases of PICC abuse. Five patients (17%) during OPAT and one patient (3%) during the 30-day follow-up period required readmission for infective or treatment-related complications.
CONCLUSIONS: Appropriately selected, counselled and monitored patients with a history of being an IVDU can be treated safely and successfully via OPAT centres. It is likely that some will respond better to treatment in an outpatient setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864497     DOI: 10.1093/jac/dkq355

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data.

Authors:  Asher J Schranz; Aaron Fleischauer; Vivian H Chu; Li-Tzy Wu; David L Rosen
Journal:  Ann Intern Med       Date:  2018-12-04       Impact factor: 25.391

2.  Outpatient parenteral antimicrobial therapy.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  Intravenous drug abuse and tricuspid valve endocarditis: Growing trends in the Middle East Gulf region.

Authors:  Prashanth Panduranga; Seif Al-Abri; Jawad Al-Lawati
Journal:  World J Cardiol       Date:  2013-11-26

4.  Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections.

Authors:  Camelia E Marculescu; Elie F Berbari; J Robert Cantey; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

5.  The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Danielle Ciuffetelli; Warren Bilker; Anne Norris; Daniel Timko; Alex Rosen; Jennifer S Myers; Janet Hines; Joshua Metlay
Journal:  J Pharm Technol       Date:  2013-10

6.  Outpatient Parenteral Antimicrobial Therapy in Vulnerable Populations-- People Who Inject Drugs and the Homeless.

Authors:  Alison Beieler; Amalia Magaret; Yuan Zhou; Anneliese Schleyer; Anna Wald; Shireesha Dhanireddy
Journal:  J Hosp Med       Date:  2019-02       Impact factor: 2.960

7.  Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey.

Authors:  E G Muldoon; G M Allison; D Gallagher; D R Snydman; C Bergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-01       Impact factor: 3.267

8.  Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence.

Authors:  Eavan G Muldoon; David R Snydman; Elizabeth C Penland; Geneve M Allison
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

9.  Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Ayse P Gurses; Sara E Cosgrove
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

Review 10.  Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.

Authors:  Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2019-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.